Specifically, Sox2 was detected in individual cases of melanoma, lung small cell and adenocarcinoma, clear cell renal cell carcinoma, squamous cell carcinoma, and poorly-differentiated carcinomas of unproven origin. This evidence concerns the gene SOX2 and clear cell renal carcinoma.